Clinical Trials Directory

Trials / Completed

CompletedNCT06704243

Peer Support Group for Adolescent and Young Adult (AYA) Allogeneic Stem Cell Transplant Recipients

Peer Support Group for AYA Allogeneic Stem Cell Transplant Recipients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
All
Age
18 Years – 39 Years
Healthy volunteers
Not accepted

Summary

Allogeneic Haemopoietic Stem Cell Transplant (Allo-HSCT) is a potentially curative option for patients with both malignant and non-malignant hematological disorders. There appears to be unique experiences that adolescents and young adults (AYA) face when undergoing transplant. There is literature to suggest that peer support for young adults is associated with improvements in mental health including greater happiness, self-esteem and effective coping, as well as reductions in depression, loneliness and anxiety. Our primary objective is to determine the feasibility and acceptability of an AYA peer support program for patients undergoing Allo-HSCT. Our secondary objective is to explore the impact of the AYA peer support program on sense of support/connectivity, anxiety, and depression.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPeer SupportThe intervention will be a monthly online AYA peer support group (1 hour) that will run for six months via Microsoft Teams. In an effort to evaluate a patient-driven "real-world" intervention, the support group has been designed with the following features: 1) participants will be asked to commit for a six month period, but are able to miss sessions if necessary; and, 2) each session will be facilitated by a Nurse Practitioner and Social Worker from the Allo-HSCT program, but the topics of discussion will be determined by the AYA participants present at each session. Participants in the group will then be invited to share their thoughts and experiences about these topics, with as much information as they feel comfortable.

Timeline

Start date
2024-05-24
Primary completion
2025-02-07
Completion
2025-02-07
First posted
2024-11-26
Last updated
2026-01-06

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06704243. Inclusion in this directory is not an endorsement.